Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,623 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,623 in last 12 months

Showing 90819100 of 13,380 recalls

DrugMarch 23, 2016· TMIG Inc

Recalled Item: Renovo Patch (Capsaicin Recalled by TMIG Inc Due to Marketed Without An...

The Issue: Marketed Without An Approved NDA/ANDA: product is an unapproved drug and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 23, 2016· Hospira Inc.

Recalled Item: Magnesium Sulfate Inj. Recalled by Hospira Inc. Due to Failed pH...

The Issue: Failed pH Specifications: Confirmed high out of specification (OOS) results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 18, 2016· Hospira Inc.

Recalled Item: 8.4% Sodium Bicarbonate Injection Recalled by Hospira Inc. Due to Presence...

The Issue: Presence of Particulate Matter: particulate matter identified as an insect...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMarch 17, 2016· Impax Laboratories, Inc.

Recalled Item: Fenofibrate Capsules (Micronized) 200 mg Recalled by Impax Laboratories,...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp. Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 17, 2016· Impax Laboratories, Inc.

Recalled Item: Fenofibrate Capsules (Micronized) 134 mg Recalled by Impax Laboratories,...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp. Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 16, 2016· Actavis Pharma Inc

Recalled Item: Ciprofloxacin Ophthalmic Solution (0.3% as base) Recalled by Actavis Pharma...

The Issue: Failed Impurities/Degradation Specifications: Firm voluntarily recalled...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 15, 2016· Hospira Inc.

Recalled Item: Quelicin (Succinylcholine Chloride) Injection Recalled by Hospira Inc. Due...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 0 (PGE 20 mcg/mL) Injection Recalled by Meditech Laboratories, Inc...

The Issue: Lack of Assurance of Sterility: incomplete or missing data regarding production.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 3 (Papaverine 20 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Stability Does Not Support Expiry: manufactured with an active ingredient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 9 (Papaverine 0.9 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Lack of Assurance of Sterility: incomplete or missing data regarding production.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 2 (Papaverine 9 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Superpotent Drug: one ingredient was found to be above assay specification.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Impax Laboratories, Inc.

Recalled Item: Dextroamphetamine Sulfate Tablets USP Recalled by Impax Laboratories, Inc....

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Impax Laboratories, Inc.

Recalled Item: Dextroamphetamine Sulfate Tablets USP Recalled by Impax Laboratories, Inc....

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 1 (Papaverine 1.8 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Stability Does Not Support Expiry: manufactured with an active ingredient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 2 (Papaverine 9 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Stability Does Not Support Expiry: manufactured with an active ingredient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 4 (Papaverine 18 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Lack of Assurance of Sterility: incomplete or missing data regarding production.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient Recalled...

The Issue: CGMP Deviations: active pharmaceutical ingredient intermediates failed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund